Featured Research

from universities, journals, and other organizations

HIV Research Takes Promising New Direction

Date:
December 14, 2000
Source:
American Chemical Society
Summary:
A new family of anti-viral compounds has proved 100 times more potent than the original in laboratory studies and opened a promising new direction in AIDS research. The compounds, called guanidinoglycosides, are intended to prevent HIV from forming and spreading throughout the body, according to Yitzhak Tor, who led the research team at the University of California, San Diego.

A new family of anti-viral compounds has proved 100 times more potent than the original in laboratory studies and opened a promising new direction in AIDS research. These related developments are described in the current (December 6) issue of the Journal of the American Chemical Society and the December 29 issue of the Journal of Organic Chemistry. Both publications are peer-reviewed journals of the American Chemical Society, the world's largest scientific society.

The compounds, called guanidinoglycosides, are intended to prevent HIV from forming and spreading throughout the body, according to Yitzhak Tor, who led the research team at the University of California, San Diego. Chemically modified from existing antibiotics known as aminoglycosides, the new compounds target the genetic structure of the virus essential to its replication, he said.

Specifically, they target the "Rev" protein that is responsible for producing and spreading HIV-infected cells. Without this protein, viral cells would be unable to reproduce and the disease would be disarmed, Tor said. By working with the virus's genetics, the researchers have found a place less prone to mutations that could lead to drug resistance, he added.

"If we can use drugs that prevent Rev from creating new viral cells, the HIV genetic material becomes useless," Tor said. "While numerous other groups explore more traditional approaches to anti-viral therapy, we believe that certain sites - like the rev intersection site - are promising and underutilized targets for anti-HIV drug design."

Aminoglycoside antibiotics have not been used to treat HIV because of their side effects and inefficiency in preventing the spread of the virus, Tor said. Guanidino groups are more promising, he believes. But it will be years before human testing could begin.

"We think this is an important direction for HIV research," Tor said. "We hope these compounds can inhibit the interactions that allow the HIV to spread. This area is still in the dark ages, so there's plenty of opportunity for progress."

The research cited above was funded by research grants from the U.S. National Institutes of Health and the University of California AIDS research program.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "HIV Research Takes Promising New Direction." ScienceDaily. ScienceDaily, 14 December 2000. <www.sciencedaily.com/releases/2000/12/001214083156.htm>.
American Chemical Society. (2000, December 14). HIV Research Takes Promising New Direction. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2000/12/001214083156.htm
American Chemical Society. "HIV Research Takes Promising New Direction." ScienceDaily. www.sciencedaily.com/releases/2000/12/001214083156.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins